Stephen Scelsa is a Neurology physician affiliated with Mount Sinai Beth Israel. OpenAlex indexes 68 publications with 2,161 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 Union Sq E
New York, NY 100033314
Telephone
212-844-8888Registry record last updated 4 Jun 2014.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
76.4%Gabapentinoids18.8%Gabapentin85%Pregabalin15%Part D<11 patientsOther nervous system drugs13.9%Radicava Ors100%Part D≥32 patients+ 13 more classes in this area
Cancer & immunology
7.8%Purine Antimetabolite6.4%Azathioprine100%Part D≥28 patientsNonsteroidal Anti-inflammatory Drug0.7%Celecoxib100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.9%Corticosteroid6.9%Prednisone100%Part D≥28 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Journal of Neurology Neurosurgery & Psychiatry
2022 - Primary lateral sclerosis natural history study – planning, designing, and early enrollment
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Newman, MD
Mount Sinai Beth Israel
Ramesh Gowda, MD
Mount Sinai Beth Israel
Michael Serby, MD
Mount Sinai Beth Israel
Albert Min, MD
Mount Sinai Beth Israel
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”